AAV transduction of dopamine neurons with constitutively active rheb protects from neurodegeneration and mediates axon regrowth

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · see citing works

Cellular survival: a play in three Akts

Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216 · see citing works

AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY

FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529 · see citing works

GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons

Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206 · see citing works

The Nerve Growth Factor 35 Years Later

Levi‐Montalcini, R. (1987) · Science · doi:10.1126/science.3306916 · Cited by 3,109 · see citing works

mTOR signaling at a glance

Laplante, M., & Sabatini, D. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,317 · see citing works

The GDNF family: Signalling, biological functions and therapeutic value

Airaksinen, M. S., & Saarma, M. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn812 · Cited by 1,832 · see citing works

Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N., & Heywood, P. (2003) · Nature Medicine · doi:10.1038/nm850 · Cited by 1,290 · see citing works

Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease

Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J. L., Chen, E., Palfi, S., Roitberg, B. Z., et al. (2000) · Science · doi:10.1126/science.290.5492.767 · Cited by 1,244 · see citing works

The TSC1–TSC2 complex: a molecular switchboard controlling cell growth

Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237 · see citing works

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson’s disease: an open label, phase I trial

Kaplitt, M. G., Feigin, A., Tang, C., Fitzsimons, H. L., Mattis, P., Lawlor, P. A., Bland, R. J., Young, D., Strybing, K., Eidelberg, D., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60982-9 · Cited by 1,067 · see citing works

Clinical progression in Parkinson disease and the neurobiology of axons

Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012 · see citing works

Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease

Lang, A. E., Gill, S., Patel, N., Lozano, A., Nutt, J. G., Penn, R., Brooks, D. J., Hotton, G. R., Moro, E., Heywood, P., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20737 · Cited by 987 · see citing works

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat

Sauer, H., & Oertel, W. H. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90605-x · Cited by 807 · see citing works

Chemotropic Responses of Retinal Growth Cones Mediated by Rapid Local Protein Synthesis and Degradation

Campbell, D. S., & Holt, C. E. (2001) · Neuron · doi:10.1016/s0896-6273(01)00551-7 · Cited by 797 · see citing works

PI 3-kinase, Akt and cell survival

Downward, J. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2004.01.002 · Cited by 783 · see citing works

A complex interplay between Akt, TSC2 and the two mTOR complexes

Huang, J., & Manning, B. D. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370217 · Cited by 724 · see citing works

Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy

Choi-Lundberg, D. L., Lin, Q., Chang, Y., Chiang, Y. L., Hay, C. M., Mohajeri, H. M., Davidson, B. L., & Bohn, M. C. (1997) · Science · doi:10.1126/science.275.5301.838 · Cited by 622 · see citing works

Turning behaviour in animals

PYCOCK, C. (1980) · Neuroscience · doi:10.1016/0306-4522(80)90048-2 · Cited by 610 · see citing works

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

Zigmond, M. J., Abercrombie, E. D., Berger, T. W., Grace, A. A., & Stricker, E. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90112-n · Cited by 609 · see citing works

Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony

Foster, K. G., & Fingar, D. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.094003 · Cited by 532 · see citing works

The expanding TOR signaling network

Martin, D. E., & Hall, M. N. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.02.008 · Cited by 496 · see citing works

Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by instrastriatal injection of 6-hydroxydopamine

Przedbroski, S., Leviver, M., Jiang, H., Ferreira, M., Jackson-Lewis, V. R., Donaldson, D. M., & Togasaki, D. M. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00066-r · Cited by 453 · see citing works

Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches

Thoenen, H., & Sendtner, M. (2002) · Nature Neuroscience · doi:10.1038/nn938 · Cited by 336 · see citing works

Localized striatal delivery of GDNF as a treatment for Parkinson disease

Kirik, D., Georgievska, B., & Björklund, A. (2004) · Nature Neuroscience · doi:10.1038/nn1175 · Cited by 289 · see citing works

PTEN/mTOR and axon regeneration

Park, K. K., Liu, K., Hu, Y., Kanter, J. L., & He, Z. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.12.032 · Cited by 285 · see citing works

CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism

Silva, R. M., Ries, V., Oo, T. F., Yarygina, O., Jackson-Lewis, V. R., Ryu, E. J., Lu, P. D., Marciniak, S. J., Ron, D., Przedborski, S., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03428.x · Cited by 285 · see citing works

Tuberous sclerosis complex proteins control axon formationPreprint

Choi, Y.-J., Nardo, A. D., Kramvis, I., Meikle, L. M., Kwiatkowski, D. J., Şahin, M., & He, X. (2008) · Genes & Development · doi:10.1101/gad.1685008 · Cited by 258 · see citing works

Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms

Dunlop, E. A., & Tee, A. R. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.012 · Cited by 257 · see citing works

Involvement of Akt in neurite outgrowth

Read, D. E., & Gorman, A. M. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0057-8 · Cited by 210 · see citing works

Crossroads in GDNF therapy for Parkinson's disease

Sherer, T., Fiske, B. K., Svendsen, C. N., Lang, A. E., & Langston, J. W. (2006) · Movement Disorders · doi:10.1002/mds.20861 · Cited by 172 · see citing works

Receptors of the Glial Cell Line-Derived Neurotrophic Factor Family of Neurotrophic Factors Signal Cell Survival through the Phosphatidylinositol 3-Kinase Pathway in Spinal Cord Motoneurons

Soler, R. M., Dolcet, X., Encinas, M., Egea, J., Bayascas, J. R., & Comella, J. X. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09160.1999 · Cited by 172 · see citing works

c-Src Is Required for Glial Cell Line-Derived Neurotrophic Factor (GDNF) Family Ligand-Mediated Neuronal Survival via a Phosphatidylinositol-3 Kinase (PI-3K)-Dependent Pathway

Encinas, M., Tansey, M. G., Pierchala, B. A., Comella, J. X., Milbrandt, J., & Johnson, E. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01464.2001 · Cited by 169 · see citing works

Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease

Ries, V., Henchcliffe, C., Kareva, T., Rzhetskaya, M., Bland, R. J., During, M. J., Kholodilov, N. G., & Burke, R. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606401103 · Cited by 168 · see citing works

Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease

Rosenblad, C., Martı́nez-Serrano, A., & Björklund, A. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00269-8 · Cited by 152 · see citing works

Dopaminergic pathway reconstruction by Akt/Rheb‐induced axon regeneration

Kim, S. R., Chen, X. M., Oo, T. F., Kareva, T., Yarygina, O., Wang, C., During, M. J., Kholodilov, N. G., & Burke, R. E. (2011) · Annals of Neurology · doi:10.1002/ana.22383 · Cited by 143 · see citing works

Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells

Urano, J., Sato, T., Matsuo, T., Otsubo, Y., Yamamoto, M. P., & Tamanoi, F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608510104 · Cited by 140 · see citing works

Akt Suppresses Retrograde Degeneration of Dopaminergic Axons by Inhibition of Macroautophagy

Cheng, H.-C., Kim, S. R., Oo, T. F., Kareva, T., Yarygina, O., Rzhetskaya, M., Wang, C., During, M. J., Tallóczy, Z., Tanaka, K., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5519-10.2011 · Cited by 136 · see citing works

Translation Factor eIF4E Rescues Cells from Myc-dependent Apoptosis by Inhibiting Cytochromec Release

Li, S., Takasu, T., Perlman, D., Peterson, M. S., Burrichter, D., Avdulov, S. V., Bitterman, P. B., & Polunovsky, V. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208821200 · Cited by 114 · see citing works

Identification of novel single amino acid changes that result in hyperactivation of the unique GTPase, Rheb, in fission yeast

Urano, J., Comiso, M. J., Guo, L., Aspuria, P.-J. P., Deniskin, R., Tabancay, A. P., Kato‐Stankiewicz, J., & Tamanoi, F. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04877.x · Cited by 94 · see citing works

Effects of GDNF on 6‐OHDA‐induced death in a dopaminergic cell line: Modulation by inhibitors of PI3 kinase and MEK

Ugarte, S. D., Lin, E., Klann, E., Zigmond, M. J., & Perez, R. G. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10632 · Cited by 89 · see citing works

Regulation of the Development of Mesencephalic Dopaminergic Systems by the Selective Expression of Glial Cell Line-Derived Neurotrophic Factor in Their Targets

Kholodilov, N. G., Yarygina, O., Oo, T. F., Zhang, H., Sulzer, D. L., Dauer, W. T., & Burke, R. E. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4506-03.2004 · Cited by 86 · see citing works

JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration

Ries, V., Silva, R. M., Oo, T. F., Cheng, H., Rzhetskaya, M., Kholodilov, N. G., Flavell, R. A., Kuan, C.-Y., RAKIC, P. T., & Burke, R. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05713.x · Cited by 81 · see citing works

Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor1

Avruch, J., Long, X., Lin, Y., Ortiz-Vega, S., Rapley, J., Papageorgiou, A., Oshiro, N., & Kikkawa, U. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370223 · Cited by 72 · see citing works

Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat

Martı́, M. J., Saura, J., Burke, R. E., Jackson-Lewis, V. R., Jiménez, A., Bonastre, M., & Tolosa, E. S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03694-6 · Cited by 70 · see citing works

Hyperactivation of Mammalian Target of Rapamycin (mTOR) Signaling by a Gain-of-Function Mutant of the Rheb GTPase

Yan, L., Findlay, G. M., Jones, R., Procter, J., Cao, Y., & Lamb, R. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600028200 · Cited by 67 · see citing works

Antiapoptotic and Trophic Effects of Dominant-Negative Forms of Dual Leucine Zipper Kinase in Dopamine Neurons of the Substantia Nigra<i>In Vivo</i>

Chen, X., Rzhetskaya, M., Kareva, T., Bland, R., During, M. J., Tank, A. W., Kholodilov, N., & Burke, R. E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2132-07.2008 · Cited by 62 · see citing works

Inhibition of Phosphatidylinositol 3‐Kinase Activity Blocks Cellular Differentiation Mediated by Glial Cell Line‐Derived Neurotrophic Factor in Dopaminergic Neurons

Pong, K., Xu, R., Baron, W., Louis, J., & Beck, K. D. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71051912.x · Cited by 54 · see citing works

Characterization of the Rheb‐mTOR Signaling Pathway in Mammalian Cells: Constitutive Active Mutants of Rheb and mTOR

Sato, T., Umetsu, A., & Tamanoi, F. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)38021-x · Cited by 43 · see citing works

Programmed cell death and new discoveries in the genetics of parkinsonism

Burke, R. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05106.x · Cited by 32 · see citing works

BDNF as a Promising Therapeutic Agent in Parkinson’s Disease

Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504 · see citing works

mTOR in Brain Physiology and Pathologies

Bockaert, J., & Marin, P. (2015) · Physiological Reviews · doi:10.1152/physrev.00038.2014 · Cited by 360 · see citing works

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease

Subramaniam, S., & Federoff, H. J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00176 · Cited by 343 · see citing works

Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival

Saxena, S., Roselli, F., Singh, K., Leptien, K., Julien, J.-P., Gros-Louis, F., & Caroni, P. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.027 · Cited by 275 · see citing works

Retrograde Axonal Degeneration in Parkinson Disease

Tagliaferro, P., & Burke, R. E. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-150769 · Cited by 272 · see citing works

Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders

Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182 · see citing works

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease

Tonges, L., Frank, T., Tatenhorst, L., Saal, K. A., Koch, J. C., Szego, E. M., Bahr, M., Weishaupt, J. H., & Lingor, P. (2012) · Brain · doi:10.1093/brain/aws254 · Cited by 176 · see citing works

Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains

Babij, R., Lee, M., Cortes, E. P., Vonsattel, J., Faust, P. L., & Louis, E. D. (2013) · Brain · doi:10.1093/brain/awt238 · Cited by 175 · see citing works

Reinstating Aberrant mTORC1 Activity in Huntington’s Disease Mice Improves Disease Phenotypes

Lee, J. H., Tecedor, L., Chen, Y. H., Mas, A., Sowada, M. J., Thompson, L. M., & Davidson, B. L. (2014) · Neuron · doi:10.1016/j.neuron.2014.12.019 · Cited by 148 · see citing works

Beneficial Effects of Flavonoids Against Parkinson's Disease

Jung, U. J., & Kim, S. R. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.4078 · Cited by 150 · see citing works

Control of Reactive Oxygen Species for the Prevention of Parkinson’s Disease: The Possible Application of Flavonoids

Kim, T. Y., Leem, E., Lee, J. M., & Kim, S. R. (2020) · Antioxidants · doi:10.3390/antiox9070583 · Cited by 128 · see citing works

Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System

Kim, B.-W., Jeong, K. H., Kim, J., Jin, M., Kim, J., Lee, M., Choi, D., Won, S.-Y., McLean, C., Jeon, M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4261-15.2016 · Cited by 118 · see citing works

Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models

Kosillo, P., & Bateup, H. S. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.700968 · Cited by 110 · see citing works

Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model

Yang, W., Chen, Y., Liu, H., & Qu, H. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2356 · Cited by 105 · see citing works

The pathobiology of perturbed mutant huntingtin protein–protein interactions in Huntington's disease

Wanker, E. E., Ast, A., Schindler, F., Trepte, P., & Schnoegl, S. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14853 · Cited by 99 · see citing works

Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development

Joseph, C., Mangani, A. S., Gupta, V. B., Chitranshi, N., Shen, T., Dheer, Y., Devaraj, K. B., Mirzaei, M., You, Y., Graham, S. L., et al. (2020) · Aging and Disease · doi:10.14336/ad.2019.0923 · Cited by 97 · see citing works

Mitophagy regulates integrity of mitochondria at synapses and is critical for synaptic maintenance

Han, S., Jeong, Y. Y., Sheshadri, P., Su, X. Y., & Cai, Q. (2020) · EMBO Reports · doi:10.15252/embr.201949801 · Cited by 92 · see citing works

Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease

Leem, E., Nam, J. H., Jeon, M., Shin, W.-H., Won, S.-Y., Park, S., Choi, M., Jin, B. K., Jung, U. J., & Kim, S. R. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.03.006 · Cited by 96 · see citing works

(ADP-ribose) polymerase 1 and AMP-activated protein kinase mediate progressive dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease

Kim, T. W., Cho, H. M., Choi, S. Y., Suguira, Y., Hayasaka, T., Setou, M., Koh, H. C., Hwang, E. M., Park, J., Kang, S. J., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.447 · Cited by 95 · see citing works

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease

Oh, S., Chang, M., Song, J., Rhee, Y., Joe, E.-H., Lee, H., Yi, S., & Lee, S. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404610 · Cited by 95 · see citing works

Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis

Wang, H., Yang, B., Qiu, L., Yang, C., Kramer, J. A., Su, Q., Guo, Y., Brown, R. H., Gao, G., & Xu, Z. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt454 · Cited by 95 · see citing works

Involvement of brain-derived neurotrophic factor signaling in the pathogenesis of stress-related brain diseases

Numakawa, T., & Kajihara, R. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1247422 · Cited by 88 · see citing works

Induction of GDNF and BDNF by hRheb(S16H) Transduction of SNpc Neurons: Neuroprotective Mechanisms of hRheb(S16H) in a Model of Parkinson’s Disease

Nam, J. H., Leem, E., Jeon, M.-T., Jeong, K. H., Park, J.-W., Jung, U. J., Kholodilov, N., Burke, R. E., Jin, B. K., & Kim, S. R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8729-2 · Cited by 76 · see citing works

Tsc1-mTORC1 signaling controls striatal dopamine release and cognitive flexibility

Kosillo, P., Doig, N. M., Ahmed, K. M., Agopyan-Miu, A. H. C. W., Wong, C. D., Conyers, L., Threlfell, S., Magill, P. J., & Bateup, H. S. (2019) · Nature Communications · doi:10.1038/s41467-019-13396-8 · Cited by 74 · see citing works

Recent progress in the study of the Rheb family GTPases

Heard, J. J., Fong, V., Bathaie, S. Z., & Tamanoi, F. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.05.011 · Cited by 73 · see citing works

Naringin treatment induces neuroprotective effects in a mouse model of Parkinson's disease in vivo, but not enough to restore the lesioned dopaminergic system

Kim, H. D., Jeong, K. H., Jung, U. J., & Kim, S. R. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.10.013 · Cited by 72 · see citing works

GAPDH: Biological Properties and Diversity

Seidler, N. W. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-4716-6 · Cited by 71 · see citing works

Induction of microglial toll-like receptor 4 by prothrombin kringle-2: a potential pathogenic mechanism in Parkinson’s disease

Shin, W.-H., Jeon, M., Leem, E., Won, S.-Y., Jeong, K. H., Park, S., McLean, C., Lee, S. J., Jin, B. K., Jung, U. J., et al. (2015) · Scientific Reports · doi:10.1038/srep14764 · Cited by 65 · see citing works

Expressing Constitutively Active Rheb in Adult Neurons after a Complete Spinal Cord Injury Enhances Axonal Regeneration beyond a Chondroitinase-Treated Glial Scar

Wu, D., Klaw, M. C., Connors, T. M., Kholodilov, N. G., Burke, R. E., & Tom, V. J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0719-15.2015 · Cited by 62 · see citing works

Nobiletin Protects Dopaminergic Neurons in the 1-Methyl-4-Phenylpyridinium-Treated Rat Model of Parkinson's Disease

Jeong, K. H., Jeon, M., Kim, H. D., Jung, U. J., Jang, M. C., Chu, J. W., Yang, S. J., Choi, I. Y., Choi, M.-S., & Kim, S. R. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3241 · Cited by 58 · see citing works

Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis

Antunes, M. S., Ladd, F. V. L., Ladd, A. A. B. L., Moreira, A. L., Boeira, S. P., & Souza, L. C. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00618-y · Cited by 55 · see citing works

Rheb GTPase Regulates β-Secretase Levels and Amyloid β Generation

Shahani, N., Pryor, W., Swarnkar, S., Kholodilov, N. G., Thinakaran, G., Burke, R. E., & Subramaniam, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532713 · Cited by 48 · see citing works

Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson’s disease

Jang, H., Kim, S., Lee, J. M., Oh, Y., Park, S. M., & Kim, S. R. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000740 · Cited by 48 · see citing works

Silibinin Attenuates MPP + -Induced Neurotoxicity in the Substantia Nigra In Vivo

Jung, U. J., Jeon, M., Choi, M., & Kim, S. R. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.2926 · Cited by 47 · see citing works

Pre‐synaptic dopamine D3receptor mediates cocaine‐induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways

Collo, G., Bono, F., Cavalleri, L., Plebani, L., Pich, E. M., Millan, M. J., Spano, P., & Missale, C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07618.x · Cited by 46 · see citing works

Effects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brain

Kim, S. R., & Jung, U. J. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.139476 · Cited by 45 · see citing works

An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease

Tagliaferro, P. A., Kareva, T., Oo, T. F., Yarygina, O., Kholodilov, N. G., & Burke, R. E. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.07.009 · Cited by 43 · see citing works

Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain

Kim, H. D., Jeong, K. H., Jung, U. J., & Kim, S. R. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2015.3581 · Cited by 41 · see citing works

In Vivo AAV1 Transduction With hRheb(S16H) Protects Hippocampal Neurons by BDNF Production

Jeon, M., Nam, J. H., Shin, W.-H., Leem, E., Jeong, K. H., Jung, U. J., Bae, Y., Jin, Y., Kholodilov, N. G., Burke, R. E., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.241 · Cited by 34 · see citing works

Disease Modification for Parkinson's Disease: Axonal Regeneration and Trophic Factors

Kordower, J. H., & Burke, R. E. (2018) · Movement Disorders · doi:10.1002/mds.27383 · Cited by 34 · see citing works

Enhancing the Utility of Adeno-Associated Virus Gene Transfer through Inducible Tissue-Specific Expression

Chen, S., Johnston, J., Sandhu, A., Bish, L. T., Hovhannisyan, R. H., Jno-Charles, O. C., Sweeney, H. L., & Wilson, J. M. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2012.129 · Cited by 31 · see citing works

Pseudotyped Lentiviral Vectors for Retrograde Gene Delivery into Target Brain Regions

Kobayashi, K., Inoue, K., Tanabe, S., Kato, S., Takada, M., & Kobayashi, K. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00065 · Cited by 30 · see citing works

Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson’s Disease

Yu, Z., Yang, L., Yang, Y., Chen, S., Sun, D., Xu, H., & Fan, X. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00324 · Cited by 31 · see citing works

Retrograde gene transfer into neural pathways mediated by adeno-associated virus (AAV)-AAV receptor interaction

Sano, H., Kobayashi, K., Yoshioka, N., Takebayashi, H., & Nambu, A. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108887 · Cited by 29 · see citing works

Naringin: A Protector of the Nigrostriatal Dopaminergic Projection

Jung, U. J., Leem, E., & Kim, S. R. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.2.124 · Cited by 31 · see citing works

Perspectives of RAS and RHEB GTPase Signaling Pathways in Regenerating Brain Neurons

Schöneborn, H., Raudzus, F., Coppey, M., Neumann, S., & Heumann, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124052 · Cited by 30 · see citing works

Restoring lost nigrostriatal fibers in Parkinson’s disease based on clinically-inspired design criteria

Gordián‐Vélez, W. J., Chouhan, D., España, R. A., Chen, H.-C. I., Burdick, J. A., Duda, J. E., & Cullen, D. K. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.07.016 · Cited by 30 · see citing works

Combining Constitutively Active Rheb Expression and Chondroitinase Promotes Functional Axonal Regeneration after Cervical Spinal Cord Injury

Wu, D., Klaw, M. C., Connors, T. M., Kholodilov, N. G., Burke, R. E., Côté, M., & Tom, V. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.08.011 · Cited by 28 · see citing works

Dysregulation of Human Somatic piRNA Expression in Parkinson’s Disease Subtypes and Stages

Zhang, T., & Wong, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052469 · Cited by 29 · see citing works

The feasibility, safety, physiological and clinical effects of high-intensity interval training for people with Parkinson’s: a systematic review and meta-analysis

Harpham, C., Gunn, H., Marsden, J. F., & Connolly, L. J. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02330-6 · Cited by 27 · see citing works

Are TrkB receptor agonists the right tool to fulfill the promises for a therapeutic value of the brain-derived neurotrophic factor?

Zagrebelsky, M., & Körte, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.374138 · Cited by 28 · see citing works

Rheb-mTOR activation rescues Aβ-induced cognitive impairment and memory function by restoring miR-146 activity in glial cells

De, D., Mukherjee, I., Guha, S., Paidi, R. K., Chakrabarti, S., Biswas, S. C., & Bhattacharyya, S. N. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.04.008 · Cited by 26 · see citing works

Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2

Kosillo, P., Ahmed, K. M., Aisenberg, E. E., Karalis, V., Roberts, B. M., Cragg, S. J., & Bateup, H. S. (2022) · eLife · doi:10.7554/elife.75398 · Cited by 25 · see citing works

Gene therapy approaches in the non-human primate model of Parkinson’s disease

Pignataro, D., Sucunza, D., Rico, A. J., Dopeso‐Reyes, I. G., Roda, E., Rodriguez-Perez, A. I., Labandeira-García, J. L., Broccoli, V., Kato, S., Kobayashi, K., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1681-3 · Cited by 26 · see citing works

Expressing Constitutively Active Rheb in Adult Dorsal Root Ganglion Neurons Enhances the Integration of Sensory Axons that Regenerate Across a Chondroitinase-Treated Dorsal Root Entry Zone Following Dorsal Root Crush

Wu, D., Klaw, M. C., Kholodilov, N. G., Burke, R. E., Detloff, M. R., Côté, M., & Tom, V. J. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00049 · Cited by 22 · see citing works

Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice

Granado, N., Ares‐Santos, S., Tizabi, Y., & Moratalla, R. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9925-z · Cited by 22 · see citing works

Activation of CNTF/CNTFRα Signaling Pathway by hRheb(S16H) Transduction of Dopaminergic Neurons In Vivo

Jeong, K. H., Nam, J. H., Jin, B. K., & Kim, S. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121803 · Cited by 20 · see citing works

Neurotrophic interactions between neurons and astrocytes following AAV1‐Rheb(S16H) transduction in the hippocampus in vivo

Jeon, M., Moon, G. J., Kim, S., Choi, M., Oh, Y., Kim, D. W., Kim, H., Lee, K. J., Choe, Y., Ha, C. M., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14882 · Cited by 20 · see citing works

Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo

Leem, E., Kim, H., Choi, M., Kim, S., Oh, Y., Lee, K. J., Choe, Y., Um, J., Shin, W.-H., Jeong, J. Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0491-3 · Cited by 19 · see citing works

Control of Granule Cell Dispersion by Natural Materials Such as Eugenol and Naringin: A Potential Therapeutic Strategy Against Temporal Lobe Epilepsy

Kim, S. R. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3712 · Cited by 17 · see citing works

Protection of nigral dopaminergic neurons by AAV1 transduction with Rheb(S16H) against neurotoxic inflammation in vivo

Kim, S., Moon, G. J., Oh, Y., Park, J., Shin, W.-H., Jeong, J. Y., Choi, K. S., Jin, B. K., Kholodilov, N. G., Burke, R. E., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.261 · Cited by 17 · see citing works

Prothrombin Kringle-2: a potential inflammatory pathogen in the parkinsonian dopaminergic system

Leem, E., Jeong, K. H., Won, S.-Y., Shin, W.-H., & Kim, S. R. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.4.147 · Cited by 16 · see citing works

Induction of GDNF and GFRα-1 Following AAV1-Rheb(S16H) Administration in the Hippocampus in vivo

Yun, D., Jeon, M., Kim, H., Moon, G. J., Lee, S., Ha, C. M., Shin, M., & Kim, S. R. (2020) · Experimental Neurobiology · doi:10.5607/en19075 · Cited by 16 · see citing works

Rheb in neuronal degeneration, regeneration, and connectivity

Potheraveedu, V. N., Schöpel, M., Stoll, R., & Heumann, R. (2017) · Biological Chemistry · doi:10.1515/hsz-2016-0312 · Cited by 16 · see citing works

STAT3 protects dopaminergic neurons against degeneration in animal model of Parkinson's disease

Smit, R. D., Ghosh, B., Campion, T. J., III, Stingel, R. L., Lavell, E., Hooper, R., Fan, X., Soboloff, J., & Smith, G. M. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148691 · Cited by 14 · see citing works

Targeting GTPases in Parkinson’s disease: comparison to the historic path of kinase drug discovery and perspectives

Hong, L., & Sklar, L. A. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00052 · Cited by 14 · see citing works

AKT3 Gene Transfer Promotes Anabolic Reprogramming and Photoreceptor Neuroprotection in a Pre-clinical Model of Retinitis Pigmentosa

McDougald, D. S., Papp, T. E., Zezulin, A. U., Zhou, S., & Bennett, J. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.04.009 · Cited by 13 · see citing works

Functional Diversity

Seidler, N. W. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-4716-6_4 · Cited by 13 · see citing works

Phosphorylated S6K1 and 4E-BP1 play different roles in constitutively active Rheb-mediated retinal ganglion cell survival and axon regeneration after optic nerve injury

Jiang, J., Zhang, L., Zou, J., Liu, J., Yang, J., Jiang, Q., Duan, P., & Jiang, B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371372 · Cited by 11 · see citing works

Induction of axon growth in the adult brain: A new approach to restoration in Parkinson's disease

Padmanabhan, S., & Burke, R. E. (2017) · Movement Disorders · doi:10.1002/mds.27209 · Cited by 11 · see citing works

Effects of Silibinin Against Prothrombin Kringle-2-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System In Vivo

Leem, E., Oh, Y., Shin, W.-H., Jin, B. K., Jeong, J. Y., Shin, M., Kim, D. W., Jang, J., Kim, H., Ha, C. M., et al. (2019) · Journal of Medicinal Food · doi:10.1089/jmf.2018.4266 · Cited by 10 · see citing works

Rapamycin exerts neuroprotective effects by inhibiting FKBP12 instead of mTORC1 in the mouse model of Parkinson's disease

Zhang, Z., Shen, Z., Xie, S., Li, J., Zhang, Z., Zhang, S., Peng, B., Huang, Q., Li, M., Ma, S., et al. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110504 · Cited by 9 · see citing works

TSC-insensitive Rheb mutations induce oncogenic transformation through a combination of constitutively active mTORC1 signalling and proteome remodelling

Xie, J., Poi, S. P. D., Humphrey, S. J., Hein, L. K., Bruning, J. B., Pan, W., Selth, L. A., Sargeant, T. J., & Proud, C. G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03825-7 · Cited by 9 · see citing works

Inhibition of microglial activation and induction of neurotrophic factors by flavonoids: a potential therapeutic strategy against Parkinson′s disease

Kim, S. R. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.153678 · Cited by 8 · see citing works

Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling

Rahman, M., Nguyen, T. M., Lee, G. J., Kim, B., Park, M. K., & Lee, C. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031489 · Cited by 7 · see citing works

Therapeutic Potential of AAV1-Rheb(S16H) Transduction Against Alzheimer’s Disease

Moon, G. J., Kim, S., Jeon, M., Lee, K. J., Jang, I., Nakamura, M., & Kim, S. R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122053 · Cited by 8 · see citing works

Treatment with AAV1-Rheb(S16H) provides neuroprotection in a mouse model of photothrombosis-induced ischemic stroke

Yoon, D., Jeon, M., Woon, K. D., & Kim, S. R. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001506 · Cited by 8 · see citing works

Upregulation of Neuronal Rheb(S16H) for Hippocampal Protection in the Adult Brain

Moon, G. J., Shin, M., & Kim, S. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062023 · Cited by 8 · see citing works

Therapeutic Potential of AAV1-Rheb(S16H) Transduction against Neurodegenerative Diseases

Nam, Y., Moon, G. J., & Kim, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063064 · Cited by 7 · see citing works

Roles of Rheb(S16H) in substantia nigra pars compacta dopaminergic neurons in vivo

Jeon, M., & Kim, S. R. (2014) · Biomedical Reports · doi:10.3892/br.2014.397 · Cited by 6 · see citing works

Quantitative morphological comparison of axon-targeting strategies for gene therapies directed to the nigro-striatal projection

Padmanabhan, S., Kareva, T., Kholodilov, N. G., & Burke, R. E. (2013) · Gene Therapy · doi:10.1038/gt.2013.74 · Cited by 5 · see citing works

Interrogation of kinase genetic interactions provides a global view of PAK1-mediated signal transduction pathways

Kim, J., Seo, Y., Jo, M., Jeon, H., Kim, Y.-S., Kim, E., Seo, D., Lee, W., Kim, S. R., Yachie, N., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014831 · Cited by 5 · see citing works

Home‐Based High‐Intensity Interval Training for People With Parkinson's: A Randomized, Controlled, Feasibility Trial

Harpham, C., Gunn, H., Marsden, J. F., Bescós, R., Murgatroyd, C., & Connolly, L. J. (2025) · Health Science Reports · doi:10.1002/hsr2.71024 · Cited by 4 · see citing works

Naringin as a beneficial natural product against degeneration of the nigrostriatal dopaminergic projection in the adult brain

Kim, S. R. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.213694 · Cited by 4 · see citing works

Mammalian target of rapamycin complex 1 as an inducer of neurotrophic factors in dopaminergic neurons

Kim, S. R. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.147923 · Cited by 4 · see citing works

Expression mediated by three partial sequences of the human tyrosine hydroxylase promoter in vivo

Rolland, A., Kareva, T., Yarygina, O., Kholodilov, N. G., & Burke, R. E. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.62 · Cited by 3 · see citing works

Intracerebellar upregulation of Rheb(S16H) ameliorates motor dysfunction in mice with SCA2

Kim, S., Park, J., Eo, H., Lee, G. B., Park, S. M., Shin, M., Lee, S. E., Nam, Y., & Kim, S. R. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01504-y · Cited by 3 · see citing works

Huntington’s disease phenotypes are improved via mTORC1 modulation by small molecule therapy

St-Cyr, S., Child, D. D., Giaime, E., Smith, A. R., Pascua, C. J., Hahm, S., Saiah, E., & Davidson, B. L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273710 · Cited by 3 · see citing works

Recovery of the injured neural system through gene delivery to surviving neurons in Parkinson’s disease

Sharma, C., Kim, S., Eo, H., & Kim, S. R. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00724 · Cited by 2 · see citing works

Aminochrome-Induced Disruption of Autophagosome-Lysosome Fusion: Implications for Protein Aggregation in Parkinson’s Disease

Briceño, A., Núñez, C., Cortés, K., Pallacán, P., Salinas, N., Millán, C., Vivanco, J. F., Caro, N., Segura‐Aguilar, J., & Paris, I. B. (2026) · Antioxidants · doi:10.3390/antiox15060739 · Cited by 2 · see citing works

Structure and Function of the mTOR Activator Rheb

Marshall, C. B., Mazhab‐Jafari, M. T., Stambolic, V., & Ikura, M. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1806-1_13 · Cited by 2 · see citing works

Inhibition of Granule Cell Dispersion and Seizure Development by Astrocyte Elevated Gene-1 in a Mouse Model of Temporal Lobe Epilepsy

Leem, E., Kim, S., Sharma, C., Nam, Y., Kim, T. Y., Shin, M., Lee, S., Kim, J., & Kim, S. R. (2024) · Biomolecules · doi:10.3390/biom14030380 · Cited by 1 · see citing works

Beneficial effects of AAV1-Rheb(S16H) administration in the adult hippocampus

Kim, S. R. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.274335 · Cited by 1 · see citing works

Creating a protein-protein interaction network for alpha-synuclein

Könn, M. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7491 · Cited by 1 · see citing works

Defining The Potential Of Gene Therapy With Bone Morphogenetic Proteins As A Novel Therapeutic Approach In Parkinson's Disease

Goulding, S. R. (2021) · doi:10.34719/fhhg1227 · Cited by 1 · see citing works

ATF4 activates a transcriptional program that chronically suppresses mTOR activity promoting neurodegeneration in Parkinson’s disease modelsPreprint

Demmings, M. D., Kane, E. A., Tennyson, E. C., Hurley, K., Zhao, J. L., Cruickshanks, N. A., Ciz, V., Krupa, J. M., Pasternak, S., & Cregan, S. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.09.658667 · Cited by 1 · see citing works

Neuroprotective mechanisms of the Rheb/mTORC1 signaling pathway in the adult dopaminergic system in vivo

(2015) · Therapeutic Targets for Neurological Diseases · doi:10.14800/ttnd.302

Activation of mTor Signaling by Gene Transduction to Induce Axon Regeneration in the Central Nervous System Following Neural Injury (Addendum)

Burke, R. E. (2016) · doi:10.21236/ad1013357

In memoriam: Robert E. Burke, MD, 1949–2018

Fahn, S., Sulzer, D. L., Kang, U. J., & Bressman, S. (2019) · Movement Disorders · doi:10.1002/mds.27612

O papel de processos autofágicos nos efeitos comportamentais desencadeados pelo tratamento com canabinóides em animais cronicamente estressados

Fusse, E. J. (2019) · doi:10.11606/d.17.2019.tde-23102019-162952

Therapeutic Potential of AAV1-Rheb(S16H) Transduction against Neurodegenerative Diseases

Nam, Y., Moon, G. J., & Kim, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063064 · Cited by 7 · see citing works

Protection of nigral dopaminergic neurons by AAV1 transduction with Rheb(S16H) against neurotoxic inflammation in vivo

Kim, S., Moon, G. J., Oh, Y., Park, J., Shin, W.-H., Jeong, J. Y., Choi, K. S., Jin, B. K., Kholodilov, N. G., Burke, R. E., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.261 · Cited by 17 · see citing works

Neuroprotective mechanisms of the Rheb/mTORC1 signaling pathway in the adult dopaminergic system in vivo

(2015) · Therapeutic Targets for Neurological Diseases · doi:10.14800/ttnd.302

Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease

Ries, V., Henchcliffe, C., Kareva, T., Rzhetskaya, M., Bland, R. J., During, M. J., Kholodilov, N. G., & Burke, R. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606401103 · Cited by 168 · see citing works

Dopaminergic pathway reconstruction by Akt/Rheb‐induced axon regeneration

Kim, S. R., Chen, X. M., Oo, T. F., Kareva, T., Yarygina, O., Wang, C., During, M. J., Kholodilov, N. G., & Burke, R. E. (2011) · Annals of Neurology · doi:10.1002/ana.22383 · Cited by 143 · see citing works